Search - tctmd.com

Displaying 341 - 360 of 375

Sort: Relevancy | Date

News Daily News

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

March 13, 2012

Presentation CTO 2012

Follow-up Surveillance After Left Main PCI: Angiography vs. Stress Testing, Timing, and Avoiding Unnecessary Reintervention

Presenter: David Kandzari

February 23, 2012

Presentation CTO 2012

One Stent vs Two Stents: Evidence-Based Medicine and Cath Lab Practicalities

Presenter: David Kandzari

February 22, 2012

Presentation CTO 2012

2011/2012 Essential Left Main Update: Rapid Review of All Essential Left Main Publications and Abstracts from the Last Year

Presenter: David Kandzari

February 22, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

News Conference News

ZES, EES Noninferior to PES

November 07, 2011

News Conference News

ZES Match or Exceed Performance of Earlier DES

November 07, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

L.A. McKeown

October 14, 2011

News Daily News

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

September 12, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Daily News

Study Finds All-Comers Design Not So All Inclusive

Caitlin E. Cox

June 15, 2011

News Daily News

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

L.A. McKeown

June 15, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

Advertisement

El SLS es Efectivo contra la Reestenosis tanto Focal como Difusa del SLF

Follow-up Surveillance After Left Main PCI: Angiography vs. Stress Testing, Timing, and Avoiding Unnecessary Reintervention

One Stent vs Two Stents: Evidence-Based Medicine and Cath Lab Practicalities

2011/2012 Essential Left Main Update: Rapid Review of All Essential Left Main Publications and Abstracts from the Last Year

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

ZES, EES Noninferior to PES

ZES Match or Exceed Performance of Earlier DES

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

Six Months Sufficient for Dual Antiplatelet Therapy

FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies

Long-term Outcomes Similar for Biodegradable-Polymer, Permanent-Polymer DES

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Women Have Less Neointimal Hyperplasia Than Men With ZES

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Study Finds All-Comers Design Not So All Inclusive

Cordis Announces Plans to Discontinue Cypher Stents, Drop Nevo Development

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content